AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,070 | -4.4% | 88,112 | -0.6% | 0.00% | 0.0% |
| Q2 2023 | $1,119 | +23.0% | 88,667 | +8.2% | 0.00% | +50.0% |
| Q1 2023 | $910 | -13.7% | 81,918 | -4.8% | 0.00% | -33.3% |
| Q4 2022 | $1,055 | -99.7% | 86,056 | +131.5% | 0.00% | +200.0% |
| Q3 2022 | $387,000 | +170.6% | 37,172 | +179.8% | 0.00% | – |
| Q2 2022 | $143,000 | +12.6% | 13,285 | +5.1% | 0.00% | – |
| Q1 2022 | $127,000 | -8.6% | 12,636 | +5.1% | 0.00% | – |
| Q4 2021 | $139,000 | +26.4% | 12,019 | +5.1% | 0.00% | – |
| Q3 2021 | $110,000 | 0.0% | 11,431 | 0.0% | 0.00% | – |
| Q2 2021 | $110,000 | -19.7% | 11,431 | -18.0% | 0.00% | – |
| Q1 2021 | $137,000 | -67.1% | 13,940 | -22.9% | 0.00% | -100.0% |
| Q4 2020 | $417,000 | +63.5% | 18,086 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $255,000 | -5.9% | 18,086 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $271,000 | +61.3% | 18,086 | 0.0% | 0.00% | – |
| Q1 2020 | $168,000 | -4.0% | 18,086 | 0.0% | 0.00% | – |
| Q4 2019 | $175,000 | +60.6% | 18,086 | +32.6% | 0.00% | – |
| Q3 2019 | $109,000 | -65.9% | 13,636 | -46.9% | 0.00% | -100.0% |
| Q2 2019 | $320,000 | -7.8% | 25,700 | +0.3% | 0.00% | 0.0% |
| Q1 2019 | $347,000 | +83.6% | 25,611 | +25.0% | 0.00% | 0.0% |
| Q4 2018 | $189,000 | -23.8% | 20,494 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $248,000 | -22.5% | 20,494 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $320,000 | +38.5% | 20,494 | +33.5% | 0.00% | 0.0% |
| Q1 2018 | $231,000 | -27.8% | 15,346 | -31.1% | 0.00% | 0.0% |
| Q4 2017 | $320,000 | +50.9% | 22,281 | +54.2% | 0.00% | 0.0% |
| Q3 2017 | $212,000 | +105.8% | 14,445 | +40.2% | 0.00% | – |
| Q2 2017 | $103,000 | +41.1% | 10,300 | 0.0% | 0.00% | – |
| Q1 2017 | $73,000 | +43.1% | 10,300 | 0.0% | 0.00% | – |
| Q4 2016 | $51,000 | -66.4% | 10,300 | -50.0% | 0.00% | – |
| Q3 2016 | $152,000 | +171.4% | 20,600 | +100.0% | 0.00% | – |
| Q2 2016 | $56,000 | -35.6% | 10,300 | 0.0% | 0.00% | – |
| Q1 2016 | $87,000 | -13.0% | 10,300 | 0.0% | 0.00% | – |
| Q4 2015 | $100,000 | -30.6% | 10,300 | 0.0% | 0.00% | -100.0% |
| Q3 2015 | $144,000 | -0.7% | 10,300 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $145,000 | +30.6% | 10,300 | 0.0% | 0.00% | – |
| Q1 2015 | $111,000 | – | 10,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |